Clinical Trials Logo

Alcohol Abuse clinical trials

View clinical trials related to Alcohol Abuse.

Filter by:

NCT ID: NCT00251212 Completed - Alcohol Abuse Clinical Trials

Tailored Teen Alcohol and Violence Prevention in the Emergency Room (ER)

Start date: September 2006
Phase: N/A
Study type: Interventional

This study is designed to address both alcohol misuse and violence among adolescents ages 14-18 seeking care in an urban emergency department (ED). The study is a randomized controlled trial comparing the effectiveness of a combined Adapted Motivational Interviewing and Skills Training intervention, delivered either by a computer or by a counselor, and an informational handout control condition.

NCT ID: NCT00249405 Completed - Alcoholism Clinical Trials

Predicting Alcoholics' Treatment Responses to a Selective Serotonin Re-uptake Inhibitor (SSRI)

Start date: February 2005
Phase: Phase 2
Study type: Interventional

This study is being done to determine if citalopram is safe and effective in the treatment of alcohol dependence. A second purpose is to evaluate whether alcohol dependent individuals who differ in a specific genetic marker respond differently to citalopram. Citalopram is a drug approved by the U.S. Food and Drug Administration (FDA) for the treatment of depression. It belongs to a category of medications called selective serotonin re-uptake inhibitors or SSRIs. The U.S. FDA has not approved citalopram for the treatment of alcohol dependence. Therefore, it is being used "off-label" in this study.

NCT ID: NCT00247221 Completed - Alcohol Abuse Clinical Trials

Brief Intervention for Families of Teens Treated in the Emergency Department for an Alcohol-Related Event

Start date: October 2002
Phase: Phase 1
Study type: Interventional

The purpose of this study is to compare the effectiveness of a brief family intervention in reducing alcohol use and alcohol-related problems among families of underage drinkers (13-17 years old) who are treated in a hospital emergency department for an alcohol-related event.

NCT ID: NCT00246441 Completed - Clinical trials for Alcohol Use Disorder

Paroxetine for Comorbid Social Anxiety Disorder and Alcoholism

Start date: March 2002
Phase: Phase 4
Study type: Interventional

The purpose of the study is to determine whether an SSRI, paroxetine, improves social anxiety symptoms and alcohol use in individuals who drink to cope with social anxiety disorder.

NCT ID: NCT00246428 Active, not recruiting - Alcohol Dependence Clinical Trials

Motivational Interviewing for Alcohol-Positive Teens in the Emergency Room

Start date: January 2000
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine whether motivational interviewing is effective in reducing alcohol consumption and alcohol problems among young adults who present to an Emergency Room.

NCT ID: NCT00246415 Completed - Alcohol Abuse Clinical Trials

A Placebo-Controlled Trial of Memantine for Alcohol Dependence

Start date: November 2002
Phase: Phase 2
Study type: Interventional

The purpose of this study is to obtain a preliminary indication of the safety and effectiveness of oral memantine (40 mg/day) in alcohol dependent patients. This study is a 16-week study comparison of memantine and placebo in patients with alcohol dependence.

NCT ID: NCT00244049 Completed - Alcohol Abuse Clinical Trials

CHIPs or College Health Intervention Projects

Start date: May 2004
Phase: Phase 3
Study type: Interventional

The goal of the study is to test the efficacy of brief clinician advice in reducing the frequency of high-risk drinking and alcohol-related harm in a population of college students seeking care at five university health care clinics. High-risk drinking is defined as 1) 8 or more episodes of heavy drinking (5 or more drinks in a row) in the past 28 days for male and female students, and/or 2) 50 drinks for male and 40 drinks for female students in the past 28 days, and/or 3) 15 drinks for male and 12 drinks for female students in the past 7 days, and/or 4) One or more episode(s) of heavy drinking which includes 15 or more drinks in a row.

NCT ID: NCT00234221 Completed - Alcohol Abuse Clinical Trials

Project Health Link: Connecting Patients With Services

Start date: November 2005
Phase: N/A
Study type: Interventional

This study will compare three alternative interventions in the emergency department (ED) to promote substance abuse assessment, referral, and treatment entry: 1) a 5 session strengths-based case management model (SBCM); 2) a 2-session motivational enhancement therapy (MET); or 3) a one-time brief informational feedback (BIF) session. The primary outcome variables for this trial include follow-through on receiving an assessment and referral, and treatment engagement. Additional outcomes include degree of treatment completion, alcohol-related measures, health service utilization, health status changes, and psychosocial factors.

NCT ID: NCT00230425 Completed - Anxiety Disorders Clinical Trials

The Measurement of Mood Variability and Sustained Attention in Women With Alcohol Dependence.

Start date: February 2003
Phase: N/A
Study type: Observational

The purpose of this study is to measure daily mood changes and to find out whether these mood changes are related to the ability to maintain attention on a task. Problems with mood are more common among women however, the association between symptoms of alcohol abuse and mood syndromes is inconsistent. First we hypothesize that women with lifetime diagnoses of alcohol abuse will not demonstrate higher symptoms of anxiety, depression, neuroticism and mood variability than control groups. Second, that the severity of these symptoms will not correlate with performance on measures of sustained attention.

NCT ID: NCT00229580 Completed - Hepatitis C Clinical Trials

Health Behavior Feedback Study for Veterans With Hepatitis C

Start date: December 2003
Phase: Phase 1
Study type: Interventional

The purpose of this study was to explore whether a brief (3 session) intervention would impact health behavior of veterans with hepatitis C. The main focus of the intervention was on reduction of heavy drinking with patients who have liver disease. Other study goals were to increase the likelihood that patients would seek out substance use treatment and/or hepatitis C health care services. The study also tested the use of a liver function test called CDT/GGT in detecting heavy drinking. The main hypothesis was that a 3 session intervention with personalized feedback about health behavior would result in a reduction in alcohol use and increased use of substance use treatment and hepatology health care.